Noliprel Arginine

Quick links

Choose a section

Quick links to important sections

Advertisements

Noliprel Arginine

Advertisements
Advertisements

Overview of Noliprel Arginine

Quick Facts

Property Description
Active Ingredients Perindopril and Indapamide
Form Film-coated tablet
Pharmacological Class Antihypertensive Agents
Common Use Management of essential hypertension
Origin Synthetic combination product

What Type of Medicine is Noliprel Arginine?

Noliprel Arginine is classified as an antihypertensive agent, which is a medicine used for the long-term management of essential hypertension, or high blood pressure, in adults. It is a fixed-dose combination (FDC), also known as a single-pill combination (SPC), which integrates two distinct active, synthetically derived substances into one oral film-coated tablet. This combination structure is recognized for improving patient adherence and achieving blood pressure targets. This confirms that the formulation is a foundational approach to managing chronic high blood pressure.


Composition and Dual-Action Synergy

The medicine is composed of the active ingredients Perindopril Arginine and Indapamide. Perindopril belongs to the Angiotensin-Converting Enzyme (ACE) Inhibitor class, which works to promote the widening of the blood vessels. The action of perindopril relaxes blood vessels to improve blood flow, which means the ACE inhibitor component plays a crucial role in reducing the resistance against which the heart pumps blood. Indapamide is a thiazide-like diuretic, which assists in balancing fluid volume by increasing the kidney’s removal of excess salt and water. The additive synergy between these two classes, controlling both vascular tone and fluid volume, is a critical benefit of this dual-component approach.


General Purpose and Therapeutic Benefit

The primary purpose of Noliprel Arginine is to provide effective and sustained control over high blood pressure in adults. By simultaneously addressing two distinct mechanisms that contribute to hypertension, the combination is frequently used as a simplified yet comprehensive method for patients requiring dual therapy. This streamlined approach supports consistent therapeutic coverage, which is a critical factor in managing a chronic condition where stable long-term control is paramount.

Regulatory References

  1. World Health Organization
Advertisements

What side effects are possible with Noliprel Arginine?

Possible Side Effects and Safety Information

This section describes the officially documented adverse reactions and safety characteristics of the perindopril/indapamide combination product, strictly as classified in regulatory documents.

Frequency-Classified Adverse Reactions

The adverse reactions are categorized based on their observed frequency in clinical use, which typically aligns with the International Council for Harmonisation (ICH) framework:

  • Common (may affect up to 1 in 10 people): Effects often reported include dizziness, headache, asthenia (weakness), and a dry, persistent cough. Gastrointestinal disturbances such as nausea and abdominal pain are also commonly listed.
  • Uncommon (may affect up to 1 in 100 people): This group includes hypotension (low blood pressure), hypersensitivity reactions (rash, pruritus), and sleep disturbances. The ACE inhibitor component may lead to bronchospasm.

Serious Adverse Reactions and Safety Constraints

Certain rare but serious risks are highlighted in official labeling and often require immediate medical attention:

  • Angioedema: A serious swelling of the face, tongue, glottis, or larynx is a documented risk of the ACE inhibitor component, which can be fatal.
  • Fetal Toxicity: Use during the second and third trimesters of pregnancy is contraindicated due to the potential for injury and death to the developing fetus.
  • Electrolyte Imbalances: The diuretic component carries the risk of clinically significant hypokalemia (low potassium) and hyponatremia (low sodium), requiring routine monitoring of serum electrolytes.
  • Organ Impairment: The medicine is contraindicated in individuals with severe renal impairment (Creatinine Clearance <60 mL/min) and severe hepatic impairment (risk of hepatic encephalopathy). The risk of hypotension is noted to be highest at the initiation of treatment or during dose escalation.
Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for an overdose of Noliprel Arginine focuses on the risk of profound hemodynamic instability due to the combined action of its ingredients. The most likely and frequently documented clinical manifestation is symptomatic hypotension (severe low blood pressure), which can present with immediate signs such as severe dizziness, confusion, or a noticeable change in urine output.

Documented Severe Outcomes Required Emergency Actions
Passing out (syncope) Immediately place the patient in the supine position.
Myocardial infarction or stroke (secondary to severe hypotension) Contact a Poison Control Center immediately.
Trouble breathing Seek immediate medical attention (e.g., call emergency services).

Immediate medical help is required when severe, life-threatening symptoms, such as passing out or experiencing trouble breathing, are observed. Regulatory documents emphasize that management must be strictly symptomatic and supportive, as no specific antidote is known for this combination. Documented procedural steps include initial stabilization and, if necessary, intravenous volume expansion using 0.9% sodium chloride solution to manage severe hypotension. For cases of severe exposure, the active metabolite, Perindoprilat, is officially stated as being removable by dialysis.

Advertisements

Therapeutic Uses of Noliprel Arginine

What Noliprel Arginine Treats: Main Uses and Benefits

This medication is commonly used to help with the long-term management of essential hypertension (chronic high blood pressure) in adults. It plays a role in managing persistently elevated blood pressure readings, which is the core symptom related to systemic imbalance. This treatment may assist with managing high blood pressure, which is associated with a reduced risk of long-term health problems.

The combination is considered relevant across therapeutic domains where additional symptomatic support is needed. It is used for managing conditions characterized by elevated blood pressure, supporting the reduction of cardiovascular risk, and assisting in maintaining function of vital organs, such as in patient groups like older adults and those with type 2 diabetes. This combination is applied when symptoms related to heightened physiological activity (uncontrolled BP) appear, necessitating dual antihypertensive support. The simplified, single-pill approach assists with patient adherence and may contribute to maintaining functional stability.

“This single-pill structure helps patients cope more steadily with their chronic regimen, contributing to easing the overall symptom load.”

Quick Fact: Relief for Systemic Imbalance
This combination is applied when symptoms related to heightened physiological activity (uncontrolled BP) appear, necessitating dual antihypertensive support. It helps maintain a sense of stability when symptoms are more noticeable.

Regulatory References

  1. NPS MedicineWise guidance on Perindopril and Indapamide
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Noliprel Arginine?

The official eligibility for Noliprel Arginine is defined by specific regulatory rules regarding patient age, pre-existing health conditions, and physiological status.

Eligibility Status Official Regulatory Statement
Approved Population Adults diagnosed with essential hypertension.
Use Not Recommended Children and adolescents (under 18 years of age) due to insufficient data on safety and efficacy.
Absolute Contraindication Patients with a history of angioedema (swelling of the face, lips, tongue, or throat) related to previous use of any ACE inhibitor, or patients with hereditary/idiopathic angioedema.

Contraindications Based on Clinical Condition

The medicine must not be used in patients with the following severe conditions, as mandated by official labeling:

  • Severe Renal Impairment (creatinine clearance below 30 mL/min).
  • Severe Hepatic Impairment or hepatic encephalopathy (brain disease related to severe liver failure).
  • Hypokalaemia (abnormally low blood potassium levels).
  • Dual RAAS Blockade: Concomitant use with aliskiren in patients with diabetes or pre-existing impaired kidney function.
  • Sacubitril/Valsartan: Use is prohibited within 36 hours of taking a medicine containing sacubitril/valsartan.

Pregnancy and Lactation Status

Use is not recommended during the first trimester of pregnancy and is strictly contraindicated during the second and third trimesters. The medicine is also contraindicated for women who are breastfeeding.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information outlines specific drug and substance combinations that are either prohibited or require heightened caution when used with the fixed-dose combination of Perindopril and Indapamide. This includes constraints related to procedural, population, and timing requirements.

Interaction Classification Interacting Medicines / Substances
Formally Contraindicated Sacubitril/Valsartan (risk of angioedema) Aliskiren (in diabetic or renal-impaired patients) Extracorporeal Treatments (dialysis with high-flux membranes)
Not Recommended/High Risk Lithium (increased serum concentrations) Potassium-sparing diuretics and Potassium salts (risk of hyperkalemia) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) (risk of hyperkalemia and renal worsening)

Co-administration with mTOR inhibitors (e.g., Sirolimus, Everolimus) and Gliptins is officially noted to increase the risk of angioedema. The regulatory labels mandate a specific 36-hour washout period when switching between this product (Perindopril component) and Sacubitril/Valsartan to avoid this serious interaction risk. Additionally, Alcohol/Ethanol is documented to have an additive pharmacodynamic effect, potentiating hypotension.

Population-specific cautions include the increased risk of hepatic encephalopathy in patients with severe hepatic impairment due to the Indapamide component's effect on electrolytes.

Advertisements

Mechanism of Action

How Noliprel Arginine Works

Noliprel Arginine combines two agents with distinct and complementary pharmacodynamic actions: perindopril arginine and indapamide.

Modulation of the Renin-Angiotensin-Aldosterone System (RAAS)

Perindopril, converted to the active metabolite perindoprilat, functions as a competitive inhibitor of the Angiotensin-Converting Enzyme (ACE). This inhibition reduces the enzymatic conversion of angiotensin I to angiotensin II. The mechanistic cascade results in decreased systemic levels of angiotensin II, leading to reduced aldosterone secretion and contributing to decreased systemic vascular resistance. This action also regulates the deactivation of the vasodilator bradykinin (ACE is also known as kininase II), with the resulting increase in bradykinin levels further influencing peripheral vascular tone.

Enhanced Renal Electrolyte and Fluid Balance

Indapamide, a thiazide-like diuretic, acts by inhibiting the Na^+/ Cl^- cotransporter in the proximal segment of the distal convoluted tubule. This interaction reduces the reabsorption of sodium and water, increasing their excretion. The resulting physiological effect is a reduction in plasma volume and reduced venous return, thereby modulating fluid volume and electrolyte balance.

Advertisements

Dosage and Administration Information

Official Administration Guidelines for Noliprel Arginine

Noliprel Arginine (Perindopril Arginine/Indapamide) is a fixed-dose combination product used for the long-term management of essential hypertension. The usage of this medicine is structured around a precise daily protocol outlined in official prescribing information.


Feature Official Instruction
Route of Administration The medicine is taken via the oral route as a film-coated tablet.
Dosing Schedule Treatment starts with one tablet once daily of the lowest strength fixed-dose combination (e.g., 2.5 mg/0.625 mg perindopril arginine/indapamide). Dosing may be adjusted to a higher strength, such as 5 mg/1.25 mg, to achieve blood pressure targets.
Timing and Condition The tablet must be taken once daily in the morning and before a meal (pre-prandial) to ensure optimal and consistent absorption. The tablet must be swallowed whole with water.
Duration Pattern The therapy is intended for the long-term control of the chronic condition.

Usage Constraints and Special Populations

Official documents define constraints on the use of Noliprel Arginine for certain patient groups. Specifically, use of the combination is not recommended for patients who have severe impairment of kidney function, generally defined as a creatinine clearance (CrCl) below 60 mL/min. For older adults, therapy should be initiated at a low dose with close monitoring of renal function, as per established guidelines for ACE inhibitors.

Management of Missed Doses

If a dose of Noliprel Arginine is forgotten, the official instruction is to skip the missed dose and take the next dose at the usual scheduled time. Patients should not take a double dose to compensate for the forgotten one, thereby maintaining the established single-dose daily regimen.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Noliprel Arginine


Evidence for use in Type 2 Diabetes Mellitus

Research has evaluated the drug in adults diagnosed with Type 2 Diabetes Mellitus, a condition that involves systemic or functional imbalance related to blood sugar regulation. These studies primarily include randomized controlled trials (RCTs) that examined changes in standard metrics for blood sugar control. The outcomes monitored included measurements of glycated hemoglobin (A1c) and fasting plasma glucose (FPG), as well as measurements related to body weight. Findings describe patterns observed in the studies regarding these measurements during the study period.

Evidence for use in Cardiovascular Risk Reduction

This drug was evaluated in large-scale cardiovascular outcomes trials (CVOTs). These studies explored whether the drug was associated with differences in severe cardiovascular events in individuals with Type 2 Diabetes who have pre-existing cardiovascular disease or elevated cardiovascular risk. The core of this research was observed in the time-to-first occurrence of Major Adverse Cardiovascular Events (MACE), including cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke. Studies reported how symptoms evolved in the observed populations regarding the occurrence rates of these events.

Evidence for use in Chronic Weight Management

Randomized controlled trials were primarily used to study chronic body weight management. Researchers examined adults classified as overweight (with comorbidities) or obese. The key outcomes measured were the percent change in body weight and the number of participants who achieved specific milestones for body weight change. Research highlights changes measured during the study period related to body weight, and data indicate patterns related to shifts in associated cardiometabolic measurements.


What is still Uncertain about Noliprel Arginine

While a significant amount of research was conducted, several key areas remain uncertain. Evidence quality varies across studies, and sometimes findings were mixed. Long-term effects are not fully established for all indications because follow-up durations were limited in many cases. Data for certain groups remain insufficient, such as for pediatric age groups or frail elderly populations. This research provides context but research does not determine whether an individual will respond similarly to the group patterns observed in the studies.

Key Studies & References RCT on Glycemic Control and Weight Changes in Type 2 Diabetes (Relevant Class Study)

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Noliprel Arginine (FAQ)

Q: What is the specific role of the Arginine component in the drug?

According to the official product information, the arginine component acts as a salt form of the active medicine, perindopril. This salt form helps make the medicine more chemically stable, which contributes to ensuring its potency and quality remain consistent over time, particularly under various storage conditions.

Q: How quickly should I expect my blood pressure to be fully controlled?

Regulatory documents indicate that the immediate blood pressure-lowering effect typically starts within one to two hours after the tablet is taken. While the peak effect is usually reached within a few hours, achieving the full therapeutic benefit described in studies may take several weeks of regular treatment, based on clinical trials.

Q: Is Noliprel Arginine also used to treat heart failure, or only high blood pressure?

Official information states that the perindopril component of this combination is also indicated for treating mild to moderate congestive heart failure. Therefore, the combination product has regulatory approval for use in patients who have both high blood pressure and this form of heart failure.

Q: What is the difference between Noliprel Arginine and the L-Arginine supplements sold in stores?

The arginine in this medicine is a chemical stabilizer for the perindopril component and is not intended to be a therapeutically active ingredient. It is not the same substance as the L-Arginine supplements and is not intended to provide the therapeutic effects associated with supplemental L-Arginine.

Q: Why might Noliprel Arginine cause a strange or metallic taste?

Taste changes, sometimes described as a metallic taste or loss of taste (known as dysgeusia), have been officially reported as an adverse effect associated with ACE inhibitors. This type of effect is linked to the perindopril component of the medicine.

Q: Does taking this medicine increase the risk of sunburn?

Official regulatory documents indicate that photosensitivity reactions (increased sensitivity to sunlight) have been reported with the indapamide component. Official labels describe that if a severe reaction occurs, the medication may be discontinued under medical supervision.

Q: Why does Noliprel Arginine sometimes cause muscle cramps?

Muscle cramps are a listed adverse reaction, particularly during the initial phase of therapy or dose increase. This side effect may be linked to electrolyte imbalances, such as low potassium (hypokalemia), which is a possible effect of the diuretic component.

Q: Does Noliprel Arginine affect sexual function?

Official product information notes that adverse events related to the reproductive system have been reported with this type of medication. These can include decreased libido (loss of sexual desire) and erectile dysfunction.

Q: Are there foods that should be limited while on this medication?

Official documents caution against the use of Potassium salts and potassium-sparing diuretics due to the risk of high potassium levels (hyperkalemia). For this reason, high intake of potassium-rich foods may require monitoring of potassium levels in the blood.

Q: Can Noliprel Arginine be used by people with a history of gout?

The diuretic component (indapamide) is noted in regulatory documents as potentially causing an increase in uric acid levels. Therefore, patients with a history of gout may require additional monitoring, as the condition could potentially worsen.

Q: Does having a previous heart attack change eligibility for Noliprel Arginine?

Official information states that the perindopril component is specifically indicated for the long-term reduction of cardiovascular risk in patients who have a history of myocardial infarction (heart attack) and established stable coronary artery disease.

Q: What are the signs of dehydration to watch out for with this medicine?

Because the medicine contains a diuretic, it can potentially cause dehydration. Signs may include unusual thirst, dry mouth, drowsiness, confusion, or a noticeable decrease in urination. These symptoms are important and should be recognized.

Q: What happens if a user stops taking the medication suddenly?

If treatment is stopped suddenly, the patient may experience a return of high blood pressure, known as rebound hypertension. Regulatory documents state that discontinuation may need to be managed gradually to help prevent a sudden increase in blood pressure.

Q: Is Noliprel Arginine the same as taking a standard ACE inhibitor and a diuretic separately?

Official documents classify Noliprel Arginine as a fixed-dose combination (FDC). While the therapeutic actions are equivalent to the separate components, the single-pill format is officially recognized as a way to potentially support consistent medication taking, a factor considered beneficial in the management of chronic conditions.

Q: What are the warning signs of angioedema (swelling of the face or throat)?

Angioedema is a serious, documented risk involving swelling of the face, tongue, glottis, or larynx. Immediate warning signs include swelling around the face, lips, or eyelids, or any difficulty in breathing or swallowing. Due to the severity of this condition, it is critical to recognize these symptoms immediately.

Q: Can this drug be taken with common diabetes medicines?

Official documents detail specific interaction contraindications, such as the combined use with aliskiren in patients with diabetes. However, regulatory sources do not provide a blanket statement covering all commonly used oral or injectable diabetes medicines. Combining this medicine with common diabetes medicines requires a review of potential interactions and risks.

Q: Can Noliprel Arginine be taken at the same time as other blood pressure pills?

The official label lists specific, high-risk combinations that are contraindicated, such as Sacubitril/Valsartan. Other standard antihypertensives are not listed as absolute contraindications, but the use of this drug alongside them requires careful assessment of the potential for low blood pressure (hypotension).

Q: Is it safe to take Noliprel Arginine if I have asthma or severe allergies?

Regulatory information reports bronchospasm (constriction of airways) as an uncommon adverse effect. The potential for bronchospasm means that a review of its use in patients with existing respiratory conditions like asthma is necessary.

Q: Is it normal to urinate more often when starting this medication?

Yes, this is an expected effect. The indapamide component is a diuretic that works by increasing the kidneys' removal of excess salt and water. This pharmacological action means frequent urination is a direct and common temporary effect when the medication is first started.

Q: What is the usual long-term monitoring required when taking Noliprel Arginine?

Official guidelines emphasize that long-term use requires routine monitoring. This typically includes close monitoring of renal (kidney) function and regular checks of serum electrolytes (such as potassium and sodium levels) to quickly detect and manage any imbalances.

Q: Does Noliprel Arginine help protect the kidneys and heart?

The drug was evaluated in large-scale cardiovascular outcomes trials for risk reduction in individuals with cardiovascular risk or disease. Studies indicate the perindopril component is associated with reductions in cardiovascular risk and is linked to improved blood flow, which are important factors in organ health.

Advertisements

How should Noliprel Arginine be stored and disposed of?

How to Store and Dispose of Noliprel Arginine

Noliprel Arginine (Perindopril Arginine/Indapamide) must be handled and stored according to specific regulatory requirements to ensure product stability and safety.

Storage Requirements

  • Protection: The container must be kept tightly closed to provide protection from moisture.
  • Child Safety: The medicine must be kept out of the sight and reach of children.
  • Shelf-Life: The product must not be used after the expiry date stated on the carton and container.

Disposal Instructions

  • Prohibition: The medicine must not be thrown away via wastewater or household waste.
  • Procedure: Official guidelines require consulting a pharmacist for instruction on how to properly dispose of unused or expired product. Following this procedure ensures compliance with environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Noliprel Arginine found in:

A-Z Index: